A nanozyme based on Fe3O4 was constructed for colorimetric detection of diclofenac in pharmaceutical formulations. Firstly, an eco-friendly, rapid, and simple green approach was introduced to synthesize magnetite (Fe3O4) nanoparticles. Pomegranate peel extract was employed as a green reducing and stabilizing agent. The synthesized magnetite NPs were characterized by field emission scanning electron microscopy, transmission electron microscopy, Fourier transform infrared, ultraviolet–visible spectroscopy, energy-dispersive X-ray spectroscopy, BET, X-ray diffraction, and zeta potential (Ƶ) techniques and have an average size of 14.24 nm. In the presence of hydrogen peroxide, a redox interaction takes place, and the resulting hydroxyl promotes a colorimetric conversion from colorless to blue in the presence of 3,3′,5,5′-tetra-methyl-benzidine (TMB). In addition, diclofenac can inhibit colorimetric conversion once it competes with TMB’s interaction with hydroxyl. There is a relationship between the colorimetric distinction and the target amount. It is also obvious that there is a colorimetric distinction between diclofenac and TMB due to their competition. The signal responses to diclofenac are linear in the range of 0.1–75 mg/L, and the limit of detection is 0.01 mg/L. In practical assays of diclofenac in pharmaceutical formulations, the relative standard deviation of the sample tests is 0.51 %, and the recovery for the spiked assays is 96.93 % with an RSD of 1.68 %. The effects of different interferences were studied with recovery ranging from 95.02 to 99.93 %
Read full abstract